Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in Off-pump Coronary Artery Bypass Grafting
NCT05577871Completed
- Sponsor
- Suez Canal University
- Start
- Nov 2022
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in coronary artery disease (CAD) (2 arms), sponsored by Suez Canal University. Primary endpoints: Left Ventricular Ejection Fraction, Left Ventricular Fractional Shortening and 1 more. Started Nov 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05577871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05577871.